![]() ![]() ![]() The large study of 12,879 young adult cancer survivors is the first study to estimate the risk of heart failure among young adult cancer survivors treated with anthracyclines. Study raises awareness for patients, clinicians to monitor for heart failure symptoms, consider strategies for preventionĬHICAGO - Imagine surviving cancer only to learn the drug that saved your life has introduced a completely different health risk: heart failure.Ī new Northwestern Medicine study has found young adult cancer survivors (between 18 and 39 years old at diagnosis) were at higher risk (2.6 times) of heart failure when treated with anthracyclines, a specific category of chemotherapy that damages DNA in cancer cells.First study to estimate risk of heart failure among young adult cancer survivors treated with this category of chemotherapy.Mean age at diagnosis of heart failure was 32 years old.Journal: JACC: CardioOncology Download study PDF ![]()
0 Comments
Leave a Reply. |